Maria Bacova

Maria Bacova

Auto-generated profile, based on publicly available information

Maria Bacova

Institute of Neurobiology of Biomedical Research Center, Slovak Academy of Sciences, Soltesovej 4-6, Kosice 040 01, Slovakia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
MBMaria Bacova
Maria Bacova
KBKatarina Bimbova
Katarina Bimbova
JFJana Fedorova
Jana Fedorova
NLNadezda Lukacova
Nadezda Lukacova
JGJan Galik
Jan Galik

1 January 2021 in ARCHIVES ITALIENNES DE BIOLOGIE
Verified
Journal Article
Closed access
ASAndrea Stropkovska
Andrea Stropkovska
AKAlexandra Kisucka
Alexandra Kisucka
KBKatarina Bimbova
Katarina Bimbova
MBMaria Bacova
Maria Bacova
JGJan Galik
Jan Galik
NLNadezda Lukacova
Nadezda Lukacova
Due to the complexity of pathological processes in spinal cord injury (SCI), it is increasingly recognized that combined strategies are more effective than single treatments. The aim of the present study was to enhance neural tissue regeneration and axon regrowth using Rho-A-kinase inhibitor (Y-27632) in a rat SCI model (Th9 compression) and to bridge the lesion with a chitosan/collagen porous scaffold (ChC-PS) applied two weeks after SCI. In addition, to see the synergic effect of Y-27632 and ChC-PS, we combined these single therapeutic strategies to enhance the regenerative capacity of injured spinal cord tissue. The animals survived eight weeks. Application of Y-27632 modulated the inhibitory milieu by specifically targeting gray and white matter integrity, glial fibrillary acidic protein (GFAP)-immunoreactivity, and the outgrowth of neurofilaments and growth-associated protein-43 (GAP-43) immunoreactive axons across the lesion sites, leading to significant positive functional outcome from day 20 to 56. Compared to single treatments, combined Y-27632/ChC-PS therapy was more effective in neurofilaments and GAP-43 expression and GFAP immunoreactivity in the perilesional area of dorsal, lateral and ventral columns, and in enhancing the gray and white matter integrity throughout the cranio-caudal extent. The findings indicate that combined therapy provides a supportive environment for endogenous regenerative processes.

25 February 2025 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
MMMartina Magurova
Martina Magurova
MBMaria Bacova
Maria Bacova
SPStefania Papcunova
Stefania Papcunova
KBKatarina Bimbova
Katarina Bimbova
TKTomáš Kuruc
Tomáš Kuruc
JGJan Galik
Jan Galik
Spinal cord trauma represents a significant clinical challenge, and improving patient outcomes is a main priority for many scientific teams globally. Despite advances in the understanding its pathogenesis, the overall mechanisms occurring in the spinal cord after traumatic injury remain unclear. This study explores the possible synergistic effects of a regenerative therapy that combines electrical stimulation with the anti-inflammatory drug Atorvastatin (ATR) after spinal cord injury (SCI). SCI was induced at the T9 segment under isoflurane anesthesia and applying a compression force of 40 g for 15 minutes. An oscillating field stimulator (OFS) was implanted subcutaneously, delivering a weak electric current (50 µA) that changed polarity every 15 minutes for six weeks to promote axonal growth at the injury site. Female Wistar albino rats were divided into four groups: SCI with non-functional stimulator (SCI + nOFS), SCI with functional stimulator (SCI+OFS), and two groups that received ATR together with stimulator for 7 days after injury (SCI+OFS+ATR, SCI+nOFS+ATR). Behavioral tests (hot-plate test and BBB scale) showed improvement in sensory and motor performance in animals treated with the combination therapy. The protein levels of astrocytes (GFAP), neurofilaments (NF-L), newly sprouting axons (GAP-43), and oligodendrocytes (PLP -1, CNPase) were analysed by Western blot. The results showed increased neurofilaments, newly sprouting axons and oligodendrocytes in groups receiving both individual and combination therapies, with a decrease in their concentrations in the following order: SCI+OFS+ATR, SCI+nOFS+ATR, SCI+OFS, SCI+nOFS. In addition, astrocyte protein levels were lower in the SCI+OFS+ATR group compared with others. Histological analysis showed a significant reduction in white and gray matter after SCI, but less white and gray matter volume loss was found in the groups receiving therapies (SCI+OFS+ATR, SCI+nOFS+ATR, SCI+OFS). These results suggest that the combination of Atorvastatin with OFS stimulation promotes neural recovery after SCI, highlighting the potential of combination therapies in enhancing regenerative outcomes.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
AKAlexandra Kisucka
Alexandra Kisucka
KBKatarina Bimbova
Katarina Bimbova
MBMaria Bacova
Maria Bacova
MIMaria Ileninova
Maria Ileninova
TKTomáš Kuruc
Tomáš Kuruc
NLNadezda Lukacova
Nadezda Lukacova

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
NLNadezda Lukacova
Nadezda Lukacova
KBKatarina Bimbova
Katarina Bimbova
AKAlexandra Kisucka
Alexandra Kisucka
MBMaria Bacova
Maria Bacova
MIMaria Ileninova
Maria Ileninova
JGJan Galik
Jan Galik

11 November 2026 in European Journal of Neuroscience
Verified
Journal Article
Closed access
KBKatarina Bimbova
Katarina Bimbova
AKAlexandra Kisucka
Alexandra Kisucka
TKTomáš Kuruc
Tomáš Kuruc
MIMaria Ileninova
Maria Ileninova
KKKarolina Kucharova
Karolina Kucharova
NLNadezda Lukacova
Nadezda Lukacova